Noveome: Noveome Biotherapeutics, Inc. Commences Phase 1 Clinical Study of ST266 Application for Infectious Disease (including COVID-19)
PITTSBURGH, June 23, 2021 /PRNewswire/ -- Noveome Biotherapeutics, Inc. (Noveome) announced that it has commenced its Phase 1 clinical trial by do...
Read full article »
Noveome is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of inflammatory and neurological disorders.
Read more